Download full-text PDF |
Source |
|---|---|
| http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2634644 | PMC |
| http://dx.doi.org/10.3201/eid1412.080889 | DOI Listing |
Publication Analysis
Top Keywords
Similar Publications
Evaluation of the Inaugural Pennsylvania School Nurse Mentorship Program.
J Sch Nurs
December 2024
Department of Pediatrics, Penn State College of Medicine, Hershey, PA, USA.
The role of a school nurse has evolved due, in part, to complex health conditions and the COVID-19 pandemic. In turn, nurse burnout and early retirement are contributing to school nurse shortages across the United States. Interprofessional support, training, and mentorship are needed to support school nurses new to the field.
View Article and Find Full Text PDFA blueprint for pursuing therapeutic interventions and early phase clinical trials in clonal haematopoiesis.
Br J Haematol
December 2024
Department of Medicine, Vanderbilt University School of Medicine, Vanderbilt-Ingram Cancer Center, Nashville, Tennessee, USA.
The age-associated mutational state of clonal haematopoiesis (CH) is linked to multiple adverse health outcomes. As higher risk CH can lead to progressive neoplastic or vascular disease, there is interest in developing clinical trials to mitigate risk associated with CH. Given the high prevalence of CH, data from clinical trials could have broad public health implications for screening and therapy.
View Article and Find Full Text PDFCurrent insights in ultra-rare adenylosuccinate synthetase 1 myopathy - meeting report on the First Clinical and Scientific Conference. 3 June 2024, National Centre for Advancing Translational Science, Rockville, Maryland, the United States of America.
Orphanet J Rare Dis
November 2024
Cure ADSSL1, Glendale, CA, USA.
Article Synopsis
- The first Clinical and Scientific Conference on ADSS1 myopathy took place on June 3, 2024, at NIH in Maryland, focusing on this rare inherited neuromuscular disease.
- The conference highlighted geographical patient clusters from South Korea, Japan, India, and the USA, along with research on pre-clinical models to better understand the disease.
- Experts identified biochemical pathways for potential therapies and created an ADSS1 myopathy consortium to guide new treatment development.
Elexacaftor/tezacaftor/ivacaftor and mental health: A workshop report from the Cystic Fibrosis Foundation's Prioritizing Research in Mental Health working group.
J Cyst Fibros
November 2024
Department of Child and Adolescent Psychiatry, Massachusetts General Hospital, Boston, MA, USA. Electronic address:
Background: This report summarizes the 2023 inaugural annual meeting of the Cystic Fibrosis Foundation's Prioritizing Research in Mental Health (PRIME) working group. This workshop focused on mental health and elexacaftor/tezacaftor/ivacaftor (ETI).
Methods: We reviewed existing literature and identified key gaps and study design considerations in preclinical work, pharmacokinetics/pharmacodynamics, mood/anxiety, quality of life/self-perception, neuropsychological symptoms, sleep, and symptom management.
EUNOS 2024: Conference Report Rotterdam, The Netherlands, 3rd-6th June 2024.
Neuroophthalmology
September 2024
Department of Neurology, Royal Hallamshire Hospital, Sheffield, UK.
The 16th biennial European Neuro-ophthalmology Society (EUNOS) meeting took place in Rotterdam, Netherlands, from June 3-6, 2024. This landmark event attracted nearly 400 scientists and clinicians worldwide, featuring groundbreaking presentations, symposia, and posters. Notably, it hosted the world's first symposium on Artificial Intelligence (AI) in Neuro-ophthalmology and introduced the inaugural Young Investigators' platform session.
View Article and Find Full Text PDFWant AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!